Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01241617
Other study ID # Juntendo-530
Secondary ID
Status Terminated
Phase N/A
First received July 30, 2010
Last updated January 22, 2012
Start date August 2010
Est. completion date January 2012

Study information

Verified date January 2012
Source Medtronic - MITG
Contact n/a
Is FDA regulated No
Health authority Japan: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The objective of this study is to confirm superiority between a test treatment group using Endo GIA stapler with Duet Tissue Reinforcement System (TRS) and a current international standard of care group using a conventional stapler in patients undergoing pulmonary lobectomy surgery, using a randomized comparative study of the frequency of intraoperative air leak.


Description:

Air leak is a complication of pulmonary surgical procedures that include pulmonary lobectomy, segmentectomy, and bullectomy, reported to occur in 33% to 75% of cases.

Prolonged air leak continuing for more than 7 days is reported to have a prevalence of greater than 15%. The presence of a history of smoking, preoperative steroid use, emphysema, low pulmonary function, pleural adhesion, and apical lung wedge resection are shown to be risk factors for prolonged air leak which lengthens the duration of drain placement, increases the days of hospitalization, and reduces patient ADL and QOL. Prolonged air leak may also result in serious complications, such as empyema.

Tissue reinforcement materials widely used as a pleural reinforcement to prevent air leaks during lung surgery, and are reported as a safe and effective material for body tissue reinforcement. Covidien Japan Inc. has developed a surgical stapler (Endo GIA Duet TRS) with an attached reinforcement material. This study will investigate the reinforcement effect on the staple line of using the newly developed surgical stapler with an attached reinforcement material.


Recruitment information / eligibility

Status Terminated
Enrollment 100
Est. completion date January 2012
Est. primary completion date January 2012
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 79 Years
Eligibility Inclusion Criteria:

- The patient is between 20-79 years of age.

- The patient is eligible to be given pulmonary Lobectomy.

- The patient is scheduled to undergo pulmonary Lobectomy.

- Performance status 0~1 (Eastern Cooperative Oncology Group classification).

- The patient has no history of lung surgery.

- The patient is healthy organ function.

- The patient is scheduled for surgery with staplers .

- The patient must be willing and able to participate in the study procedures and able to understand and sign the informed consent.

Exclusion Criteria:

- The patient has suffered thoracic trauma or has previously undergone pneumonectomy surgery.

- The patient has an active bacterial infection or fungal infection.

- The patient is undergoing continuing systemic administration (intravenous or oral) of steroids.

- The patient condition is complicated by uncontrolled diabetes mellitus.

- The patient participation is judged difficult due to study complications related to a psychiatric disorder or psychological symptoms.

- The patient undergoes surgical procedure other than lobectomy during surgery.

- Reinforcement material other than the study materials are applied during surgery.

- The patient judged unsuitable for study participation by the investigator for any other reason.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Duet TRS
Endo GIA stapler with integrated Duet TRS
Endo GIA
Endo GIA stapler with Single Use Loading Units

Locations

Country Name City State
Japan Junendo University School of Medicine Tokyo

Sponsors (1)

Lead Sponsor Collaborator
Medtronic - MITG

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of intraoperative air leak Occurence of intraoperative air leak will vary from patient to patient and will be recorded for all patients. Day 0 Yes
Secondary Postoperative duration of air leak Duration of air leak will vary from patient to patient. Published literature states a duration of greater than 7 days occurs in 15% of patients. Month 1 (Average time period) No
Secondary Duration of chest drainage Duration of chest drainage will vary from patient to patient. Month 1 (Average time period) No
Secondary Frequency of intraoperative sealant use The need to use a sealant intraoperatively will be assessed for each patient during surgery. Day 0 No
Secondary Incidence of intraoperative adverse events The occurence of adverse events during surgery will be recorded for each patient. Day 0 No
Secondary Incidence of postoperative adverse events Patients are not required to return to the clinic at a specific time point. Any adverse events that occur after discharge will be captured. Month 1 (Average time period) No
Secondary Days of hospitalization Discharge date will vary from patient to patient Month 1 (Average time period) No
See also
  Status Clinical Trial Phase
Withdrawn NCT02253667 - Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients N/A
Completed NCT02217423 - Abdominal Circumference and Cardiorespiratory Repercussions in Patients Submitted to Physical Therapy N/A
Completed NCT02345135 - Susceptibility to Infections in Ataxia Telangiectasia N/A
Completed NCT01679301 - Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator N/A
Terminated NCT00966823 - Fetal Tracheal Balloon Study in Diaphragmatic Hernia Phase 2
Completed NCT00139152 - Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair Phase 4
Completed NCT00052052 - An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) Phase 2
Completed NCT00013949 - Cardiovascular Vulnerability to Particulate Exposure N/A
Recruiting NCT02963467 - Effect of Smoking on Ventilation-Perfusion Ratio N/A
Recruiting NCT02965300 - The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis N/A
Enrolling by invitation NCT02946658 - Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders Phase 1/Phase 2
Recruiting NCT02913365 - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis N/A
Completed NCT01735526 - Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Hematopoietic Stem-cell Transplantation N/A
Completed NCT01952002 - Clinical Safety for the Inspiratory Muscle Training N/A
Recruiting NCT01450644 - Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease Phase 2
Completed NCT01153321 - Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Completed NCT01215279 - AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD) Phase 2
Completed NCT00837681 - Pulmonary Complications of Hematopoietic Stem Cell Transplantation N/A
Completed NCT02055222 - Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Completed NCT01222442 - To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart Phase 1